Midas Letter is the Journal of ‘Best-in-class’ Companies in All Sectors.

“I’m Not Telling Subscribers What to Invest In. I’m Telling You What I’m Investing In.”

My inclination toward investing in and covering emerging company segment is based on an affinity for and love of entrepreneurialism, and the ‘never say die’ spirit that embodies it. All mega-cap, multinational, blue-chip stocks began life as a startup. Without a steady flow of new companies up the economic ladder into profitable enterprises ripe for acquisition, the mega-caps would stagnate and die.

Start-ups are where all the big ideas are born. It is in start-up companies that visionary leadership ignores the naysayers in single-minded pursuit of an idea that is worthwhile, and usually a benefit to humanity.

With start-ups, I can easily reach management. In fact, I’m on a first name, call anytime-basis with probably two-thirds of all TSX Venture CEOs. The financial statements are uncomplicated and no forensic mindset is required, as is the case with mega-caps, where ‘off-balance sheet entities’ were born.

– James West | Founder of Midas Letter

Free Newsletter,
Priceless Content.

Receive exclusive 2020 sector reports based on your interests.

Our Favourite Articles

Check out some of our most popular articles that describe our investment philosophies in different markets and sectors.

Let Me Introduce Myself

|

I weighed in on a Twitter feed that was talking about the Iran war the other day, and, in true Twitter form, somebody made a dismissive comment about my tweet saying, [...]

Midas Letter Favourites

|

It’s a civic holiday here in Canada. Most Canadians are at the cottage chilling and grilling, so we think it’s the perfect time to look back and reflect on our efforts in creating memorable content for our subscribers. [...]

The Disrupted Universe

|

This month, I launched a new product called “The Disruptors”. I wanted to talk today about why I am so thrilled to have this new service rolling out on the Wealth Press platform.  [...]

Understanding Gold and Why its Going to Explode Higher

|

I am no longer surprised by how misunderstood gold is in the historical monetary context. Detractors like to point out its uselessness as a fungible unit of trade (you can’t buy a loaf of bread with a bar of gold) while wizened investors maintain a 10-15% allocation to gold in the event of a systemic failure in monetary currencies. [...]

Get Ready for the Reg A+ Revolution

|

Capital markets are broken. As I write this, the S&P TSX Venture Index is flirting with intra-decade lows (again). The cannabis industry is in the trough of a deep re-valuation to the downside, [...]

Rise of the Cannabis Corp: The Second Wave is Here

|

Among the valuable outcomes of the Biden/Harris win for investors is the clear path now laid out to full federal decriminalization and regulation of cannabis. Both Biden and Harris are unequivocal in their support for broad access to cannabis across recreational and medicinal landscapes and will move quickly to demonstrate that commitment. [...]

Top Performing Stocks

In the last 12 months, here are our carefully chosen picks and their performance to date.

WEED.TO

Canopy Growth Corporation

Cost Basis 1.21     Highest Price 5223.97      2528.93%

First Mention on Midas Letter | Oct 21, 2015

OGI.V

OrganiGram Holdings Inc.

Cost Basis 2.20     Highest Price 9.97      353.18%

First Mention on Midas Letter | Sep 3, 2014

LAC.TO

Lithium Americas Corp.

Cost Basis 1.04     Highest Price 13.56      1203.85%

First Mention on Midas Letter | Apr 17, 2012

XMG.CN

MGX Minerlas Inc.

Cost Basis 0.19     Highest Price 2.28      1100%

First Mention on Midas Letter | Feb 21, 2017

TSCRF

Score Media and Gaming Inc.

Cost Basis 0.2581     Highest Price 0.79      206.08%

First Mention on Midas Letter | May 15, 2018

SHOP

Shopify Inc.

Cost Basis 326.34     Highest Price 1031.74      216.15%

First Mention on Midas Letter |

WLYYF

WELL Health Technologies Corp.

Cost Basis 0.9153     Highest Price 6.79      641.83%

First Mention on Midas Letter | Nov 15, 2018

VXRT

Vaxart Inc

Cost Basis 1.32     Highest Price 17.49      1225%

First Mention on Midas Letter | Mar 30, 2020

NVAX

Novavax Inc.

Cost Basis 13.34     Highest Price 189.4      1319.79%

First Mention on Midas Letter | Mar 30, 2020